4th Diabetes Partnering and Deal Making Conference
Or sign up 3 colleagues for the price of 2 with the coupon code RCDVB!

Dear Colleague,

Join leaders and decision makers at GTC’s 4th Diabetes Partnering and Deal-Making Conference, part of the Diabetes Summit 2014 on April 23-25 in Cambridge, MA. The Diabetes Partnering & Deal-Making Conference is a partnering and business development program that gives companies an opportunity to network with high-level executives and explore potential collaborations, learn about relevant issues and deals that will affect the industry.

The conference is part of GTC's annual Diabetes Summit which includes two co-located conferences:
4th Diabetes Partnering and Deal-Making
7th Diabetes Drug Discovery and Development

Below is the program at-a-glance. For further detailed information, follow the links below:
To view the 2014 agenda, click here.
To view the 2014 speaker list, click here.

2014 PROGRAM AT A GLANCE
General Session
Joint sessions with Diabetes Summit and 2014 Stem Cell Summit
Topics:
I. Cell Therapy and Diabetes - Stem Cell Research in the Diabetes Space


Conference I:
4th Diabetes Partnering and Deal-Making


Conference II:
7th Diabetes Drug Discovery and Development
Plenary Keynote Session
• Hans-Juergen Woerle, Vice President and Head of Therapeutic Area Metabolism, Boehringer Ingelheim
• Steven E. Nissen, Chairman of Cardiovascular Medicine, Cleveland Clinic Foundation

Panel Discussion: Type 1 Diabetes: "The New Honeymoon that Last Decades" - Clinical trial opportunities and the new diverse type 1 diabetic population - can we more accurately predict complications?
Participants:
Denise Faustman, Harvard Medical School
Corinth Auld, Mercodia
Richard Oram, Exeter

Diabetes Partnering and Deal-Making
Continued
Diabetes Drug Discovery and Development
Continued
Sessions:
I. Innovative Partnering & Licensing Strategies
II. Partnering Opportunities in Diabetes Drug Development
Panel Discussions:
I. Wining Strategies in Partnering & Deal-Making
II. Partnering with Non-Profits
III. Finding the Middle Ground in Big Pharma and Biotech Partnerships
IV. Partnering with Academia
V. Investment Opportunities in the Diabetes Space

For the detailed agenda click here

Sessions:
I. New Therapeutic Targets for Diabetes
II. Combination Therapy
III. Clinical Drug Development in Diabetes
IV. Advances in Obesity Drug Development









For the detailed agenda click here



The conference will run parallel with the 7th Diabetes Drug Discovery and Development Conference.

Sign up for the summit pass to have access to both tracks of the summit. Or bring a team of 3 for the price of 2 by registering with the coupon code rcdvb!

We look forward to seeing you at the conference!

Best regards,

2014 Conference Advisory Committee



PLATINUM SPONSOR
SILVER SPONSOR
SUPPORTING SPONSOR
MEDIA PARTNERS
FEATURED PARTICIPANTS
Brian T. Bloomquist
Senior Director, Global External Research and Development
Eli Lilly
-
John Brooks
President & CEO
Joslin Diabetes Center, Harvard Medical School
-
Steven Cohen
Executive Director, External Scientific Affairs, Cardiovascular-Metabolism & Frontiers
Translational Medicine and Clinical Pharmacology
Daiichi Sankyo
-
Larry Deckelbaum
Vice President, Scientific Partnership Strategy, Cardiovascular and Metabolism Therapeutic Area
Janssen
-
Jeff Karan
Founder and Senior Partner Woodside Capital-
-

Tomas Landh

Director, Strategy & Sourcing
Novo-Nordisk
-
Hans-Juergen Woerle
Vice President & Head of Therapeutic Area Metabolism
Boehringer Ingelheim

QUOTES
"This conference was a very good opportunity to strengthen the connection between big pharma, biotech and academics, through a good mix between panel discussion, case studies, companies presentation and networking opportunity." - CEO, Poxel


"Excellent conference to engage with industry and academic collaborators and to learn about advances in technology in a setting that is very conducive to discussion and networking." - CEO, Joslin Diabetes Center


"The GTC Diabetes Summit converged stakeholders in discovery, translational development, commercialization and care delivery in a diabetes-focused conference that stimulated discussion, ideas, and networking so critical for advancing innovation to address the current global challenges. It was a high-value, engaging conference.” - CEO, Exsulin
Attend ALL GTC Conferences for One Year for only $3,995 ($1,990 for Acad/Govt).
Click here to sign up!